Caricamento...
Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma
BACKGROUND: Live attenuated influenza vaccine (LAIV) is recommended for annual influenza vaccination in children from age 2 years. However, some guidelines recommend against its use in children with asthma or recurrent wheeze due to concerns over its potential to induce wheezing. OBJECTIVE: We sough...
Salvato in:
| Pubblicato in: | J Allergy Clin Immunol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Mosby
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7156909/ https://ncbi.nlm.nih.gov/pubmed/31863808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2019.12.010 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|